Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Enanta Pharmaceuticals Inc (NASDAQ: ENTA) closed at $5.57 down -0.18% from its previous closing price of $5.58. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 0.89 million shares were traded. ENTA stock price reached its highest trading level at $5.73 during the session, while it also had its lowest trading level at $5.435.
Ratios:
For a deeper understanding of Enanta Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.21 and its Current Ratio is at 5.21. In the meantime, Its Debt-to-Equity ratio is 1.75 whereas as Long-Term Debt/Eq ratio is at 1.48.
On August 08, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $49 to $18.
On December 09, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $56.H.C. Wainwright initiated its Buy rating on December 09, 2022, with a $56 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 06 ’24 when Kieffer Tara Lynn sold 2,283 shares for $8.06 per share. The transaction valued at 18,401 led to the insider holds 29,305 shares of the business.
Luu Brendan sold 2,283 shares of ENTA for $18,401 on Dec 06 ’24. The Chief Business Officer now owns 36,047 shares after completing the transaction at $8.06 per share. On Dec 06 ’24, another insider, Rottinghaus Scott T., who serves as the Chief Medical Officer of the company, sold 866 shares for $8.06 each. As a result, the insider received 6,980 and left with 17,918 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENTA now has a Market Capitalization of 118052256 and an Enterprise Value of 186998032. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.74 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at 2.599 whereas that against EBITDA is -1.554.
Stock Price History:
Over the past 52 weeks, ENTA has reached a high of $17.80, while it has fallen to a 52-week low of $5.30. The 50-Day Moving Average of the stock is -35.57%, while the 200-Day Moving Average is calculated to be -53.79%.
Shares Statistics:
For the past three months, ENTA has traded an average of 345.44K shares per day and 753850 over the past ten days. A total of 21.19M shares are outstanding, with a floating share count of 19.73M. Insiders hold about 6.90% of the company’s shares, while institutions hold 100.36% stake in the company. Shares short for ENTA as of 1730332800 were 3440099 with a Short Ratio of 9.76, compared to 1727654400 on 2985735. Therefore, it implies a Short% of Shares Outstanding of 3440099 and a Short% of Float of 17.26.
